# FDA Inspection 1056313 - Regenerative Biologics - April 27, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/regenerative-biologics/2d244619-b73b-4f91-a666-1ba6d7086dea
Source feed: FDA_Inspections

> FDA Inspection 1056313 for Regenerative Biologics on April 27, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1056313
- Company Name: Regenerative Biologics
- Inspection Date: 2018-04-27
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.globalkeysolutions.net/companies/regenerative-biologics/220d9327-9c52-4c37-8ecb-2c85656d9bfb

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d